Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Subscribe To Our Newsletter & Stay Updated
